Company news

Sona Nanotech, Inc. news in 2026

Sona Nanotech, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Sona Nanotech Announces Chief Technology Officer and Annual Options Grants

October 13, 2026

Sona Nanotech to Present at the OTC Markets’ Life Sciences Virtual Investor Forum On September 17th

September 11, 2026

Sona Nanotech Closes Over-Subscribed Private Placement Financing to Raise $2,527,012 in Gross Proceeds

August 10, 2026

SONA Nanotech to arrange private placement financing

July 31, 2026

Sona Nanotech Appoints Seasoned Biotech Commercial Executive Michael A. Fleming to Board of Directors

June 11, 2026

Sona Nanotech Announces Clinical Strategy With Two THT Combination Therapy Studies In Melanoma

May 5, 2026

Sona Nanotech Showcases Cancer Therapy Results At Prestigious Industry Cancer Conferences

April 27, 2026

Sona Nanotech Announces Appointment of Two Leading Oncologists To Its Scientific Advisory Board

April 16, 2026

Sona Nanotech Clinical Cancer Study Tissue Analysis Confirms Tumor Priming And Suggests Potential Immunotherapy Synergies

April 13, 2026

Sona Nanotech's THT Cancer Therapy Demonstrates Strong Efficacy And Durability In Combination with Immunotherapy In Peer-reviewed Preclinical Study

April 7, 2026

Sona Nanotech To Hold Investor Webinar To Discuss Follow-up Data From First-in-human Cancer Therapy Study

March 16, 2026

Decks in 2026